Julie
is a real patient
with RA, performing
an everyday activity...
Indication
A) Diseases which do not show sufficient response to the existing therapies:
1. Rheumatoid arthritis (RA) (including inhibition of progression of structural joint damage)
2. Polyarticular-course juvenile idiopathic arthritis (pJIA),
3. Systemic juvenile idiopathic arthritis (sJIA)
B) Castleman’s disease: Improvement of various symptoms (e.g. generalised fatigue) and laboratory findings (increased C-reactive protein, fibrinogen, and erythrocyte sedimentation rate, decreased haemoglobin and albumin).
Reference:
ACTEMRA® (tocilizumab) Full Prescribing Information. Current at September 2008